这些发现提供了更多证据，表明了在可食用动物身上使用氟喹诺酮类药物会带来哪些问题。
The findings add to the growing body of evidence suggestive of the problems of using fluoroquinolonones in food-producing animals.
目的是探讨外排泵在嗜麦芽窄食单胞菌中对氟喹诺酮类药物的耐药性中的作用。
The objective is to explore the role of efflux pump in drug resistance to fluoroquinolones in Stenotrophomonas maltophilia.
对喹诺酮类药物过敏的患者忌用。
This drug is not for patients who have shown hypersensitivity to quinolones.
目前较为理想的药物是口服睾酮类药物。
结论应高度重视氟喹诺酮类药物的不良反应。
CONCLUSION Attach the highly importance to ADRs of the fluoroquinolones.
应用表面活性剂胶束水溶液，纸色谱分离黄酮类药物。
Discussed the migraction of flavonoids in micellar Paper Chromatography.
结论老年人及特殊人群应慎重选择使用喹诺酮类药物；
Conclusion The elderly and special populations should be carefully chosen to use quinolones;
开发出一批具有新颖结构的黄酮类药物的先导化合物。
This paper systematically summarize current researches in the SAR studies of flavonoids and their derivatives, which can serve as a reference for synthesizing new flavonoid derivatives.
几项临床试验开展了噻唑烷二酮类药物预防糖尿病的研究。
There are several trials on prevention of diabetes with TZDs.
使用抗生素，特别是使用氟喹诺酮类药物，是一个危险因素。
Antibiotic use, especially use of fluoroquinolones, is a risk factor.
药敏试验结果表明，重组菌株失去对喹诺酮类药物的抗药性。
Do antibiotics sensitivity test on its recombinant strains, but no resistance of Quinolone can be found.
CCCP等能量抑制剂可加强细菌对氟喹诺酮类药物的摄取量。
The energy resistance inhibiter, such as CCCP, can intensify bacterial ingestion to fluoroquinolone drugs.
目的探讨大肠埃希菌靶位基因突变对喹诺酮类药物耐药的影响。
Objective To investigate the effects of target gene mutations on the quinolones resistance in Escherichia coli.
用离子抑制色谱进行水溶液中氧氟沙星等喹诺酮类药物含量的分析。
The contents of quinolone medicines such as ofloxacin etc in aqueous solution are analyzed by ion inhibition chromatography.
噻唑烷二酮类药物是一类新的治疗2型糖尿病和胰岛素抵抗的药物。
Thiazolidinediones (TZDs) are a new class of agents commonly used for the treatment of patients with type 2 diabetes or insulin resistance.
噻唑烷二酮类药物的应用存在一些问题，因为这类药物有一些副作用。
Thiazolodinediones are a problem because they seem to have some side effects associated with them.
结果喹诺酮类药物在我院的使用逐年增加，成为抗菌药物中主要用药。
Results the amount of utilization of FQNLs increased year by year, FQNLs became the main medicine.
噻唑烷二酮类药物是上世纪九十年代发明的，现被用于治疗2型糖尿病。
The drugs were introduced in the 1990s and are used to treat type 2 diabetes.
在正确的方向显示积极的数据，所以我要说匹格列酮类药物可能是安全的。
"The PROACTIVE data went in the right direction, so I would say pioglitazone was probably safe," he said.
结果：归纳总结出氟喹诺酮类药物的不良反应发生的一般规律和有关特征。
RESULTS: The general rule and characteristics of occurrence of adverse reactions resulted from quinolones have been summarized.
目的：探讨主动外排泵在嗜麦芽寡养单胞菌对氟喹诺酮类药物耐药中的作用。
Objective:To explore the role of efflux pump in drug resistance to fluoroquinolones in Stenotrophomonas maltophilia.
控制组的治疗方案包括安慰剂，常规护理和非噻唑啉二酮类药物抗糖尿病治疗。
Treatments used in the control groups included placebo, usual care, and non-TZD antidiabetic therapies.
注意：不要以为氟喹诺酮类药物对假单胞菌都有相同的功效，因为这不是事实；
NOTES: do not assume that all fluoroquinolones have equal efficacy against Pseudomonas, because they don't;
目的研究导致大肠埃希菌dna回旋酶a亚单位的基因变异耐喹诺酮类药物的机制。
OBJECTIVE to study the mutation in DNA gyrase a of Escherichia coli resistante to quinolone antibiotics.
喹诺酮类药物在临床中广泛应用于治疗各种感染，但是在其应用中也发现了许多不良反应。
Quinolones antibacterials have been used widely in the treatment of many kinds of infectious disease in clinic.
结果氟喹诺酮类药物具有不错的市场应用前景，但需注意可能的不良反应及耐药性的发生。
Results the results indicate that fluoroquinolone had perfect market prospect, however, the possible adverse drug reactions and resistance should be paid much attention.
更令人烦恼的是，这已经引发了所有噻唑烷二酮类药物和所有PPAR方面药物的使用问题。
Even more worrisome, this has called into question the use of all thiazolidinediones and all PPAR-directed agents.
吡格列酮是一种噻唑烷二酮类药物，可以改善胰岛素敏感性并且改善2型糖尿病的糖脂代谢。
Pioglitazone is a thiazolidinedione that ameliorates insulin resistance and improves glucose and lipid metabolism in type 2 diabetes mellitus.
但人型枝原体、解脲脲原体的喹诺酮类药物耐药株对YH16、YH17也存在交叉耐药性。
However, there were cross resistance YH16 and YH17 for Uu and Mh strains resistant to other quinolones.
结果皮质类固醇对肌腱的影响仍存在争议，应用喹诺酮类药物治疗可能和肌腱疾病的发生有关。
Results There still were many arguments about the effect of corticosteroid on the treatment of tendon disease.
应用推荐